Invention Grant
- Patent Title: Treatment of cancers with immunostimulatory HIV tat derivative polypeptides
-
Application No.: US14505977Application Date: 2014-10-03
-
Publication No.: US09663556B2Publication Date: 2017-05-30
- Inventor: Joshua Goldberg , Colin Bier
- Applicant: Pin Pharma, Inc.
- Applicant Address: US NY New York
- Assignee: PIN Pharma, Inc.
- Current Assignee: PIN Pharma, Inc.
- Current Assignee Address: US NY New York
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Michelle Glasky Bergman
- Main IPC: C07K14/05
- IPC: C07K14/05 ; C07K14/005 ; A61K31/664 ; A61K39/21 ; A61K38/16 ; A61K39/39
Abstract:
Disclosed herein are compositions comprising a Human Immunodeficiency Virus (HIV) trans-activator of transcription (Tat) derivative polypeptide with increased immunostimulatory properties relative to the native Tat polypeptide, pharmaceutical compositions comprising the Tat derivative polypeptide, and methods of treating cancer using the Tat derivative polypeptide.
Public/Granted literature
- US20150098960A1 TREATMENT OF CANCERS WITH IMMUNOSTIMULATORY HIV TAT DERIVATIVE POLYPEPTIDES Public/Granted day:2015-04-09
Information query
IPC分类:
